24-27 April, 2019
GP Pharm will present the results of the clinical study of the first Desmopressin in oral solution for paediatric use in plenary session.
15-19 March, 2019
Presentation of the clinical trial of GP Pharm’s Leuprolide acetate 22.5 mg recently approved by the FDA
15th March 2017
The networking-winter dinner of CataloniaBio 2017
20th July 2017
GP Pharm has been the gold sponsor of the CataloniaBio BBQ with a representation headed by Dr. Berta Ponsati, CEO of the company.
GP Pharm was present in the LXXXI Congreso Nacional de Urología held in Toledo in June.
January 14th 2016
January 22nd 2016